Jim Mellon
Overview
Jim Mellon is a British entrepreneur and investor with a diverse portfolio spanning biotechnology, technology, real estate, and financial services. After studying Philosophy, Politics, and Economics at Oxford University, he began his career in fund management with GT Management and Thornton & Co. In 1991, he established his own business, which has since evolved into the Burnbrae Group, encompassing various sectors including banking, mining, and hotels. Through Burnbrae, Mellon has substantial real estate holdings in Germany and the Isle of Man. In the biotechnology and technology sectors, Mellon co-founded Juvenescence, a company dedicated to developing therapies for aging and age-related diseases. He also co-founded Agronomics, focusing on cellular agriculture and alternative proteins. Additionally, he serves as a non-executive director for companies such as Condor Gold, Portage Biotech Inc., Bradda Head Limited, and Agronomics Limited. His leadership extends to being the executive chairman of Manx Financial Group, which owns Conister Bank. Mellon has authored several books, including "Wake Up! Survive and Prosper in the Coming Economic Turmoil," "Juvenescence: Investing in the Age of Longevity," and "Moo’s Law: An Investor’s Guide to the New Agrarian Revolution." He has also established the Mellon Longevity Centre at Oxford and is an honorary fellow of Oriel College. His investment philosophy emphasizes identifying emerging trends and capitalizing on innovative sectors to drive growth and value creation.
Investment Focus
- Focus on biotechnology and technology sectors
- Interest in companies developing therapies for aging and age-related diseases
- Preference for investments in cellular agriculture and alternative proteins
- Willingness to invest in diverse industries including banking, mining, and hotels
- Openness to global investment opportunities, particularly in the United Kingdom, United States, Germany, Isle of Man, Spain, Hong Kong, Russia, China, Brazil, South Africa, India, Australia, Canada, Japan, South Korea, Singapore, Malaysia, Thailand, Indonesia, and the Philippines
Portfolio Companies
Get the full list of 54,000+ investors
Jim Mellon and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Jim Mellon
What sectors does Jim Mellon invest in?
Jim Mellon invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Real Estate, and is based in Founded 1991. Jim Mellon is listed as a private investment firm in the ConnectSafely investor database.
What stage does Jim Mellon invest at?
Jim Mellon backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Jim Mellon invest in?
Jim Mellon invests across United States, United Kingdom, Canada, Germany, Hong Kong and Japan.
What companies has Jim Mellon invested in?
Jim Mellon's portfolio includes Juvenescence, Agronomics, Condor Gold, Portage Biotech Inc., Bradda Head Limited, Agronomics Limited, Manx Financial Group and Conister Bank.
Last updated · Source: ConnectSafely investor database
